Syneos Health is a leading global provider of integrated clinical and commercial outsourcing services to the pharmaceutical and biotechnology industries. Founded in 2017, Syneos Health resulted from the merger of two industry giants, INC Research and inVentiv Health. The headquarters of Syneos Health is located in Morrisville, North Carolina. This state-of-the-art facility serves as the company's central hub for its operations and supports its global network of offices and clinical research sites. The headquarters houses a range of departments, including finance, operations, business development, and executive leadership. Syneos Health offers a wide range of products and services to its clients. Its main offerings include clinical development, commercialization, consulting, and data analytics. The company provides end-to-end solutions throughout the drug development process, from early-phase clinical trials to post-approval commercialization. Syneos Health's integrated model allows for seamless collaboration between clinical and commercial teams, resulting in improved efficiency and speed to market for its clients. On a global scale, Syneos Health operates in more than 70 countries. The company has established a strong presence in key markets, including North America, Europe, and Asia-Pacific. Syneos Health has also developed strategic partnerships with various stakeholders in the healthcare industry. Notable subsidiaries of Syneos Health include Syneos Health Clinical Solutions, Syneos Health Consulting, and Syneos Health Communications. Syneos Health holds a prominent market position in the pharmaceutical and biotech outsourcing industry. The company had reported global sales of approximately $4.4 billion in 2020. Syneos Health competes with other major players, such as IQVIA, PPD, and Charles River Laboratories. However, its integrated service offerings and global reach set it apart from competitors, making it a preferred choice for many pharmaceutical companies. In terms of major events or achievements, Syneos Health has continued to expand its global footprint through strategic acquisitions and partnerships. Notably, in 2018, the company acquired the contract research organization (CRO) Synteract, strengthening its capabilities in early-stage clinical development. Currently, as of the latest available information, Syneos Health remains a leading player in the industry, with a strong financial performance and a growing client base. The company continues to innovate and adapt to the changing needs of the pharmaceutical industry, ensuring its position as a trusted partner for the development and commercialization of life-saving therapies.